DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13191
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMahesh, R.-
dc.date.accessioned2023-11-20T10:53:16Z-
dc.date.available2023-11-20T10:53:16Z-
dc.date.issued2010-05-
dc.identifier.urihttps://nopr.niscpr.res.in/bitstream/123456789/8483/1/IJEB%2048%285%29%20466-473.pdf-
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13191-
dc.description.abstractDisruption of normal neuronal networks and neurotransmitters like serotonin and norepinephrine levels in post traumatic brain injury (TBI) are observed to be the primary causative agent for depression/anxiety. This communication reports the efficacy of various classes' anti-depressants in the treatment of depression/anxiety following TBI in rats. Chronic treatment with anti-depressants (escitalopram and venlafaxine) leads to improvement in the depressive/anxiogenic-like behaviour in the TBI rat and corroborates the notion of the involvement of serotonin and norepinephrine in the behavioural consequences of post-TBI. Chronic treatments with escitalopram and venlafaxine significantly reversed the effect of TBI as compared to vehicle-treated TBI group. The results showed a quantitative battery of neuro-behavioural functional assessments that correlates with neuronal damage following traumatic brain injuryen_US
dc.language.isoenen_US
dc.publisherNISCAIRen_US
dc.subjectPharmacyen_US
dc.subjectTraumatic brain injury (TBI)en_US
dc.subjectAnti-depressantsen_US
dc.titleEffect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in ratsen_US
dc.typeArticleen_US
Appears in Collections:Department of Pharmacy

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.